» Articles » PMID: 12377293

Depression and Public Health: an Overview

Overview
Journal J Psychosom Res
Specialty Psychiatry
Date 2002 Oct 16
PMID 12377293
Citations 162
Authors
Affiliations
Soon will be listed here.
Abstract

Depressive disorders are a significant public health issue. They are prevalent, disabling, often chronic illnesses, which cause a high economic burden for society, related to both direct and indirect costs. Depressive disorders also influence significantly the outcome of comorbid medical illnesses such as cardiac diseases, diabetes, and cancer. In primary care, underrecognition and undertreatment of depressive disorders are common, despite their relatively high prevalence, which accounts typically for more than 10% of patients. Primary care physicians should be aware of the common risk factors for depressive disorders such as gender, neuroticism, life events and adverse childhood experiences, and they should be familiar with associated features such as a positive psychiatric family history and prior depressive episodes. In primary care settings, depressive disorders should be considered with patients with multiple medical problems, unexplained physical symptoms, chronic pain or use of medical services that is more frequent than expected. Management of depressive disorders in primary care should include treatment with the newer antidepressant agents (given the fact they are typically well tolerated and safe) and focus on concomitant unhealthy behaviors as well as treatment adherence, which may both affect patient outcome. Programs aimed at improving patient follow-up and the coordination of the primary care intervention with that of specialists have been found to improve patient outcomes and to be cost effective.

Citing Articles

Urgency Prediction for Medical Laboratory Tests Through Optimal Sparse Decision Tree: Case Study With Echocardiograms.

Jiang Y, Li Q, Huang Y, Zhang W JMIR AI. 2025; 4:e64188.

PMID: 39879091 PMC: 11822316. DOI: 10.2196/64188.


Internal migration and depressive symptoms: exploring selection and outcomes in a South African cohort.

Ginsburg C, Myroniuk T, Pheiffer C, Moffett B, White M SSM Ment Health. 2024; 6.

PMID: 39668849 PMC: 11637342. DOI: 10.1016/j.ssmmh.2024.100330.


Monoamine alterations in Alzheimer's disease and their implications in comorbid neuropsychiatric symptoms.

Saggu S, Bai A, Aida M, Rehman H, Pless A, Ware D Geroscience. 2024; 47(1):457-482.

PMID: 39331291 PMC: 11872848. DOI: 10.1007/s11357-024-01359-x.


Associations Between Reductions in Depressive Symptoms and Reductions in Pain and Anxiety Symptoms and Substance Use: Emulation of a Randomized Trial.

Khan M, Acri M, Ban K, Scheidell J, Stevens E, Manandhar-Sasaki P AJPM Focus. 2024; 3(5):100258.

PMID: 39290574 PMC: 11407062. DOI: 10.1016/j.focus.2024.100258.


The relationship between neuroticism and social aggression: a moderated mediation model.

Quan F, Gou Y, Gao Y, Yu X, Wei B BMC Psychol. 2024; 12(1):443.

PMID: 39152489 PMC: 11328397. DOI: 10.1186/s40359-024-01938-9.